Global Schizophrenia Treatments Market Research Report 2023

Report ID: 1992484 | Published Date: Oct 2024 | No. of Page: 87 | Base Year: 2023 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Schizophrenia Treatments Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Atypical Antipsychotics
        1.2.3 Phenothiazine Antipsychotics
        1.2.4 Thioxanthenes
        1.2.5 Miscellaneous Antipsychotic Agents
    1.3 Market by Application
        1.3.1 Global Schizophrenia Treatments Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospital Pharmacies
        1.3.3 Drug Stores
        1.3.4 Retail Pharmacies
        1.3.5 E-Commerce
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Schizophrenia Treatments Market Perspective (2017-2028)
    2.2 Schizophrenia Treatments Growth Trends by Region
        2.2.1 Schizophrenia Treatments Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Schizophrenia Treatments Historic Market Size by Region (2017-2022)
        2.2.3 Schizophrenia Treatments Forecasted Market Size by Region (2023-2028)
    2.3 Schizophrenia Treatments Market Dynamics
        2.3.1 Schizophrenia Treatments Industry Trends
        2.3.2 Schizophrenia Treatments Market Drivers
        2.3.3 Schizophrenia Treatments Market Challenges
        2.3.4 Schizophrenia Treatments Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Schizophrenia Treatments Players by Revenue
        3.1.1 Global Top Schizophrenia Treatments Players by Revenue (2017-2022)
        3.1.2 Global Schizophrenia Treatments Revenue Market Share by Players (2017-2022)
    3.2 Global Schizophrenia Treatments Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Schizophrenia Treatments Revenue
    3.4 Global Schizophrenia Treatments Market Concentration Ratio
        3.4.1 Global Schizophrenia Treatments Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Schizophrenia Treatments Revenue in 2021
    3.5 Schizophrenia Treatments Key Players Head office and Area Served
    3.6 Key Players Schizophrenia Treatments Product Solution and Service
    3.7 Date of Enter into Schizophrenia Treatments Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Schizophrenia Treatments Breakdown Data by Type
    4.1 Global Schizophrenia Treatments Historic Market Size by Type (2017-2022)
    4.2 Global Schizophrenia Treatments Forecasted Market Size by Type (2023-2028)
5 Schizophrenia Treatments Breakdown Data by Application
    5.1 Global Schizophrenia Treatments Historic Market Size by Application (2017-2022)
    5.2 Global Schizophrenia Treatments Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Schizophrenia Treatments Market Size (2017-2028)
    6.2 North America Schizophrenia Treatments Market Size by Country (2017-2022)
    6.3 North America Schizophrenia Treatments Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Schizophrenia Treatments Market Size (2017-2028)
    7.2 Europe Schizophrenia Treatments Market Size by Country (2017-2022)
    7.3 Europe Schizophrenia Treatments Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Schizophrenia Treatments Market Size (2017-2028)
    8.2 Asia-Pacific Schizophrenia Treatments Market Size by Country (2017-2022)
    8.3 Asia-Pacific Schizophrenia Treatments Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Schizophrenia Treatments Market Size (2017-2028)
    9.2 Latin America Schizophrenia Treatments Market Size by Country (2017-2022)
    9.3 Latin America Schizophrenia Treatments Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Schizophrenia Treatments Market Size (2017-2028)
    10.2 Middle East & Africa Schizophrenia Treatments Market Size by Country (2017-2022)
    10.3 Middle East & Africa Schizophrenia Treatments Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Johnson and Johnson
        11.1.1 Johnson and Johnson Company Detail
        11.1.2 Johnson and Johnson Business Overview
        11.1.3 Johnson and Johnson Schizophrenia Treatments Introduction
        11.1.4 Johnson and Johnson Revenue in Schizophrenia Treatments Business (2017-2022)
        11.1.5 Johnson and Johnson Recent Development
    11.2 Bristol-Myers Squibb
        11.2.1 Bristol-Myers Squibb Company Detail
        11.2.2 Bristol-Myers Squibb Business Overview
        11.2.3 Bristol-Myers Squibb Schizophrenia Treatments Introduction
        11.2.4 Bristol-Myers Squibb Revenue in Schizophrenia Treatments Business (2017-2022)
        11.2.5 Bristol-Myers Squibb Recent Development
    11.3 Otsuka
        11.3.1 Otsuka Company Detail
        11.3.2 Otsuka Business Overview
        11.3.3 Otsuka Schizophrenia Treatments Introduction
        11.3.4 Otsuka Revenue in Schizophrenia Treatments Business (2017-2022)
        11.3.5 Otsuka Recent Development
    11.4 AstraZeneca
        11.4.1 AstraZeneca Company Detail
        11.4.2 AstraZeneca Business Overview
        11.4.3 AstraZeneca Schizophrenia Treatments Introduction
        11.4.4 AstraZeneca Revenue in Schizophrenia Treatments Business (2017-2022)
        11.4.5 AstraZeneca Recent Development
    11.5 Sumitomo Dainippon Pharma
        11.5.1 Sumitomo Dainippon Pharma Company Detail
        11.5.2 Sumitomo Dainippon Pharma Business Overview
        11.5.3 Sumitomo Dainippon Pharma Schizophrenia Treatments Introduction
        11.5.4 Sumitomo Dainippon Pharma Revenue in Schizophrenia Treatments Business (2017-2022)
        11.5.5 Sumitomo Dainippon Pharma Recent Development
    11.6 Eli Lilly
        11.6.1 Eli Lilly Company Detail
        11.6.2 Eli Lilly Business Overview
        11.6.3 Eli Lilly Schizophrenia Treatments Introduction
        11.6.4 Eli Lilly Revenue in Schizophrenia Treatments Business (2017-2022)
        11.6.5 Eli Lilly Recent Development
    11.7 Alkermes
        11.7.1 Alkermes Company Detail
        11.7.2 Alkermes Business Overview
        11.7.3 Alkermes Schizophrenia Treatments Introduction
        11.7.4 Alkermes Revenue in Schizophrenia Treatments Business (2017-2022)
        11.7.5 Alkermes Recent Development
    11.8 Vanda Pharmaceuticals
        11.8.1 Vanda Pharmaceuticals Company Detail
        11.8.2 Vanda Pharmaceuticals Business Overview
        11.8.3 Vanda Pharmaceuticals Schizophrenia Treatments Introduction
        11.8.4 Vanda Pharmaceuticals Revenue in Schizophrenia Treatments Business (2017-2022)
        11.8.5 Vanda Pharmaceuticals Recent Development
    11.9 ALLERGAN
        11.9.1 ALLERGAN Company Detail
        11.9.2 ALLERGAN Business Overview
        11.9.3 ALLERGAN Schizophrenia Treatments Introduction
        11.9.4 ALLERGAN Revenue in Schizophrenia Treatments Business (2017-2022)
        11.9.5 ALLERGAN Recent Development
    11.10 Pfizer
        11.10.1 Pfizer Company Detail
        11.10.2 Pfizer Business Overview
        11.10.3 Pfizer Schizophrenia Treatments Introduction
        11.10.4 Pfizer Revenue in Schizophrenia Treatments Business (2017-2022)
        11.10.5 Pfizer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Schizophrenia Treatments Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Atypical Antipsychotics
    Table 3. Key Players of Phenothiazine Antipsychotics
    Table 4. Key Players of Thioxanthenes
    Table 5. Key Players of Miscellaneous Antipsychotic Agents
    Table 6. Global Schizophrenia Treatments Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Schizophrenia Treatments Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Schizophrenia Treatments Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Schizophrenia Treatments Market Share by Region (2017-2022)
    Table 10. Global Schizophrenia Treatments Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Schizophrenia Treatments Market Share by Region (2023-2028)
    Table 12. Schizophrenia Treatments Market Trends
    Table 13. Schizophrenia Treatments Market Drivers
    Table 14. Schizophrenia Treatments Market Challenges
    Table 15. Schizophrenia Treatments Market Restraints
    Table 16. Global Schizophrenia Treatments Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Schizophrenia Treatments Market Share by Players (2017-2022)
    Table 18. Global Top Schizophrenia Treatments Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Schizophrenia Treatments as of 2021)
    Table 19. Ranking of Global Top Schizophrenia Treatments Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Schizophrenia Treatments Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Schizophrenia Treatments Product Solution and Service
    Table 23. Date of Enter into Schizophrenia Treatments Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Schizophrenia Treatments Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Schizophrenia Treatments Revenue Market Share by Type (2017-2022)
    Table 27. Global Schizophrenia Treatments Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Schizophrenia Treatments Revenue Market Share by Type (2023-2028)
    Table 29. Global Schizophrenia Treatments Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Schizophrenia Treatments Revenue Market Share by Application (2017-2022)
    Table 31. Global Schizophrenia Treatments Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Schizophrenia Treatments Revenue Market Share by Application (2023-2028)
    Table 33. North America Schizophrenia Treatments Market Size by Country (2017-2022) & (US$ Million)
    Table 34. North America Schizophrenia Treatments Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Europe Schizophrenia Treatments Market Size by Country (2017-2022) & (US$ Million)
    Table 36. Europe Schizophrenia Treatments Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Asia-Pacific Schizophrenia Treatments Market Size by Region (2017-2022) & (US$ Million)
    Table 38. Asia-Pacific Schizophrenia Treatments Market Size by Region (2023-2028) & (US$ Million)
    Table 39. Latin America Schizophrenia Treatments Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Latin America Schizophrenia Treatments Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Middle East & Africa Schizophrenia Treatments Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Middle East & Africa Schizophrenia Treatments Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Johnson and Johnson Company Detail
    Table 44. Johnson and Johnson Business Overview
    Table 45. Johnson and Johnson Schizophrenia Treatments Product
    Table 46. Johnson and Johnson Revenue in Schizophrenia Treatments Business (2017-2022) & (US$ Million)
    Table 47. Johnson and Johnson Recent Development
    Table 48. Bristol-Myers Squibb Company Detail
    Table 49. Bristol-Myers Squibb Business Overview
    Table 50. Bristol-Myers Squibb Schizophrenia Treatments Product
    Table 51. Bristol-Myers Squibb Revenue in Schizophrenia Treatments Business (2017-2022) & (US$ Million)
    Table 52. Bristol-Myers Squibb Recent Development
    Table 53. Otsuka Company Detail
    Table 54. Otsuka Business Overview
    Table 55. Otsuka Schizophrenia Treatments Product
    Table 56. Otsuka Revenue in Schizophrenia Treatments Business (2017-2022) & (US$ Million)
    Table 57. Otsuka Recent Development
    Table 58. AstraZeneca Company Detail
    Table 59. AstraZeneca Business Overview
    Table 60. AstraZeneca Schizophrenia Treatments Product
    Table 61. AstraZeneca Revenue in Schizophrenia Treatments Business (2017-2022) & (US$ Million)
    Table 62. AstraZeneca Recent Development
    Table 63. Sumitomo Dainippon Pharma Company Detail
    Table 64. Sumitomo Dainippon Pharma Business Overview
    Table 65. Sumitomo Dainippon Pharma Schizophrenia Treatments Product
    Table 66. Sumitomo Dainippon Pharma Revenue in Schizophrenia Treatments Business (2017-2022) & (US$ Million)
    Table 67. Sumitomo Dainippon Pharma Recent Development
    Table 68. Eli Lilly Company Detail
    Table 69. Eli Lilly Business Overview
    Table 70. Eli Lilly Schizophrenia Treatments Product
    Table 71. Eli Lilly Revenue in Schizophrenia Treatments Business (2017-2022) & (US$ Million)
    Table 72. Eli Lilly Recent Development
    Table 73. Alkermes Company Detail
    Table 74. Alkermes Business Overview
    Table 75. Alkermes Schizophrenia Treatments Product
    Table 76. Alkermes Revenue in Schizophrenia Treatments Business (2017-2022) & (US$ Million)
    Table 77. Alkermes Recent Development
    Table 78. Vanda Pharmaceuticals Company Detail
    Table 79. Vanda Pharmaceuticals Business Overview
    Table 80. Vanda Pharmaceuticals Schizophrenia Treatments Product
    Table 81. Vanda Pharmaceuticals Revenue in Schizophrenia Treatments Business (2017-2022) & (US$ Million)
    Table 82. Vanda Pharmaceuticals Recent Development
    Table 83. ALLERGAN Company Detail
    Table 84. ALLERGAN Business Overview
    Table 85. ALLERGAN Schizophrenia Treatments Product
    Table 86. ALLERGAN Revenue in Schizophrenia Treatments Business (2017-2022) & (US$ Million)
    Table 87. ALLERGAN Recent Development
    Table 88. Pfizer Company Detail
    Table 89. Pfizer Business Overview
    Table 90. Pfizer Schizophrenia Treatments Product
    Table 91. Pfizer Revenue in Schizophrenia Treatments Business (2017-2022) & (US$ Million)
    Table 92. Pfizer Recent Development
    Table 93. Research Programs/Design for This Report
    Table 94. Key Data Information from Secondary Sources
    Table 95. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Schizophrenia Treatments Market Share by Type: 2021 VS 2028
    Figure 2. Atypical Antipsychotics Features
    Figure 3. Phenothiazine Antipsychotics Features
    Figure 4. Thioxanthenes Features
    Figure 5. Miscellaneous Antipsychotic Agents Features
    Figure 6. Global Schizophrenia Treatments Market Share by Application in 2021 & 2028
    Figure 7. Hospital Pharmacies Case Studies
    Figure 8. Drug Stores Case Studies
    Figure 9. Retail Pharmacies Case Studies
    Figure 10. E-Commerce Case Studies
    Figure 11. Schizophrenia Treatments Report Years Considered
    Figure 12. Global Schizophrenia Treatments Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 13. Global Schizophrenia Treatments Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Schizophrenia Treatments Market Share by Region: 2021 VS 2028
    Figure 15. Global Schizophrenia Treatments Market Share by Players in 2021
    Figure 16. Global Top Schizophrenia Treatments Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Schizophrenia Treatments as of 2021)
    Figure 17. The Top 10 and 5 Players Market Share by Schizophrenia Treatments Revenue in 2021
    Figure 18. North America Schizophrenia Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. North America Schizophrenia Treatments Market Share by Country (2017-2028)
    Figure 20. United States Schizophrenia Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada Schizophrenia Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Schizophrenia Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Schizophrenia Treatments Market Share by Country (2017-2028)
    Figure 24. Germany Schizophrenia Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. France Schizophrenia Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. U.K. Schizophrenia Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Italy Schizophrenia Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Russia Schizophrenia Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Nordic Countries Schizophrenia Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Schizophrenia Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Schizophrenia Treatments Market Share by Region (2017-2028)
    Figure 32. China Schizophrenia Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Japan Schizophrenia Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. South Korea Schizophrenia Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Southeast Asia Schizophrenia Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. India Schizophrenia Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Australia Schizophrenia Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Schizophrenia Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Latin America Schizophrenia Treatments Market Share by Country (2017-2028)
    Figure 40. Mexico Schizophrenia Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Brazil Schizophrenia Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Schizophrenia Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Middle East & Africa Schizophrenia Treatments Market Share by Country (2017-2028)
    Figure 44. Turkey Schizophrenia Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Saudi Arabia Schizophrenia Treatments Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Johnson and Johnson Revenue Growth Rate in Schizophrenia Treatments Business (2017-2022)
    Figure 47. Bristol-Myers Squibb Revenue Growth Rate in Schizophrenia Treatments Business (2017-2022)
    Figure 48. Otsuka Revenue Growth Rate in Schizophrenia Treatments Business (2017-2022)
    Figure 49. AstraZeneca Revenue Growth Rate in Schizophrenia Treatments Business (2017-2022)
    Figure 50. Sumitomo Dainippon Pharma Revenue Growth Rate in Schizophrenia Treatments Business (2017-2022)
    Figure 51. Eli Lilly Revenue Growth Rate in Schizophrenia Treatments Business (2017-2022)
    Figure 52. Alkermes Revenue Growth Rate in Schizophrenia Treatments Business (2017-2022)
    Figure 53. Vanda Pharmaceuticals Revenue Growth Rate in Schizophrenia Treatments Business (2017-2022)
    Figure 54. ALLERGAN Revenue Growth Rate in Schizophrenia Treatments Business (2017-2022)
    Figure 55. Pfizer Revenue Growth Rate in Schizophrenia Treatments Business (2017-2022)
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation
    Figure 58. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Johnson and Johnson
Bristol-Myers Squibb
Otsuka
AstraZeneca
Sumitomo Dainippon Pharma
Eli Lilly
Alkermes
Vanda Pharmaceuticals
ALLERGAN
Pfizer
Frequently Asked Questions
Schizophrenia Treatments report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Schizophrenia Treatments report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Schizophrenia Treatments report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Scissor Lifts

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More

Screen Less Display

Screen Less Display market is segmented by players, region (country), by Type and by Application. ... Read More